| Date | Form | Description | Docs | XBRL | Pages |
| 07/16/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/13/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/17/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/16/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/10/26 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
30 |
| 03/11/26 | 8-K | Current report |
|
|
24 |
| 03/09/26 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
17 | |
| 02/09/26 | 8-K | Current report |
|
|
6 |
| 01/29/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/28/26 | DEF 14A | Definitive proxy statements |
|
|
34 |
Latest News & Events
Anixa Biosciences Expands Global Patent Portfolio with Australian Patent Acceptance for Breast Cancer Vaccine Technology
Read More...Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
Read More...Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
Read More...